Submitted by Anonymous (not verified) on 13 October 2025 - 16:20
Human medicines European public assessment report (EPAR): Oxlumo, lumasiran, Date of authorisation: 19/11/2020, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Oxlumo, lumasiran, Date of authorisation: 19/11/2020, Revision: 6, Status: Authorised